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Several reports on acute eosinophilic pneumonia (AEP)
have demonstrated that activated CD4 lymphocytes and
their released cytokines can contribute to eosinophilic
accumulation in the lung (1–4). ST2 is an orphan receptor
expressed preferentially on the surface of murine helper T
cell type 2 (Th2) (5,6), and has been demonstrated to play
an essential role in the development of Th2 responses in a
murine model of eosinophilic airway inflammation (7,8).
Here we describe a case of AEP with increased levels of
soluble ST2 protein and Th2 cytokines such as interleukin
(IL)-4, IL-5, IL-6 and IL-10 in bronchoalveolar lavage fluid
(BALF), all of which then decreased with corticosteroid
treatment in parallel with disappearance of BALF eosino-
philia. Such results suggest that ST2 expression may be
involved in Th2-mediated eosinophilic inflammation in the
pathogenesis of AEP.
Case report
A previously healthy 16-year-old Japanese woman experi-
enced fever and non-productive cough in the morning,
developed dyspnoea and was admitted to Jichi Medical
School Hospital on the night of that same day. She had
started smoking (half a pack per day) one week before
admission. Her body temperature was 38?48C, and her
respiration rate was 24 breaths min71. There were no signs
of anaemia, jaundice or cyanosis. The cardiac examination
was normal and auscultation of the lungs revealed no
bilateral rales. The abdomen appeared normal, with no
organomegaly. Arterial oxygen saturation in room air was
88%. The peripheral white blood cell count was
16800min73, with 85% neutrophils, 5% lymphocytes, 3%
eosinophils and 0%monocytes. Tests for serumMycoplasma
antibody and cold agglutinins were negative. Total serumReceived 16 January 2001 and accepted in revised form 7 March
2001.
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0954-6111/01/060532+02 $35?00/0IgE was 386 IU ml71 and radioallergosorbent test (RAST)
to 16 common aeroallergens was negative. Serum level of
eosinophilic cationic protein was 43?2mg l71 (normal:
515?7 mg l71). Her chest radiograph and chest CT-scan
showed diffuse interstitial infiltrates and bilateral pleural
effusion. Bronchoalveolar lavage (BAL) yielded a cell count
of 1?346106ml71, with 56% eosinophils (Table 1). Based
on clinical findings, X-ray findings and increased eosino-
phils in BALF, a diagnosis of AEP was made and oral
predonisolone (30mg day71) was administered on the third
day of hospitalization. Her clinical symptoms and X-ray
findings gradually improved, and she was discharged after
hospitalization for 2 weeks. Predonisolone was tapered off
for 6 weeks, then ceased. There was no evidence of
recurrence after cessation of steroid therapy.
Two months after discharge, blood was taken and BAL
was performed again. The levels of soluble ST2 protein and
cytokines such as IL-4, IL-5, IL-6, IL-10 and IFNg in
serum and BALF were measured by enzyme-linked
immunosorbent assay (ELISA) (9), and were compared
between the time of admission and 2 months after discharge
(Table 1). The elevated levels of soluble ST2 protein, IL-5,
IL-6 and IL-10 in serum as well as BALF on the day of
admission dramatically decreased after treatment in parallel
with disappearance of eosinophilic accumulation in BALF.
IL-4 level was also elevated before treatment in BALF, but
not in serum, and fell to the undetectable level after
treatment. In contrast, IFNg levels in serum and BALF
before treatment were very low, and were unchanged even
after treatment.
Discussion
Although the triggering mechanism responsible for AEP is
still unknown, it is clear that eosinophils represent the
major cell population contributing to the inflammatory
reaction associated with this disorder (1). Several studies
have demonstrated that activated CD4 lymphocytes in the
lungs may play an important role in eosinophil accumula-
tion through cytokine production in AEP (2–4). Studies in
several murine models have recently demonstrated that ST2
is important for Th2 effector functions in eosinophilic# 2001 HARCOURT PUBLISHERS LTD
TABLE 1. BAL findings before and after corticosteroid
treatment
Before treatment After treatment
Cell count (ml71) 1?346106 2?16105
Cell differentiation
Macrophage (%) 26?2 87?1
Neutrophil (%) 0?8 0?6
Eosinophil (%) 56?4 5?6
Lymphocyte (%) 16?6 6?7
CD3 (%) 74?5 47?9
HLA-DR (%) 60?8 56?2
CD4/CD8 1?43 0?82
IFNg (pgml71) 9?24 7?8
(Serum, pgml71) (2?12) (51?56)*
IL-4 (pgml71) 21?9 52?5
(Serum, pgml71) (52?5)* (52?5)*
IL-5 (pgml71) 34300?0 57?3
(Serum, pgml71) (860?0) (57?3)*
IL-6 (pgml71) 308?0 11?6
(Serum, pgml71) (60?4) (50?15)*
IL-10 (pgml71) 244?0 1?88
(Serum, pgml71) (30?5) (0?64)
ST2 (ngml71) 4?65 0?153
(Serum, ngml71) (3?06) (0?868)
*Detection limit.
The titre in the parenthesis indicated serum concentration
of the cytokine.
ST2 AND ACUTE EOSINOPHILIC PNEUMONIA 533inflammation (7, 8). Our results demonstrated that the
levels of soluble ST2 protein and of Th2-cytokines in BALF
were elevated before treatment, and decreased after
treatment in parallel with disappearance of BALF eosino-
philia, while low levels of IFNg in serum and BALF before
treatment remained unchanged even after treatment. These
results suggest that ST2 expression may be implicated in
Th2 responses and its effector functions in the pathogenesis
of AEP.
In our case, the concentration of cytokines such as IL-4,
IL-5, IL-6 and IL-10 in BALF was high compared with that
in serum. This result suggests that cytokines may be locally
produced by activated Th2 cells in the lung. The results of
an experimental murine model of pulmonary eosinophilia
demonstrated that T-cell-derived IL-5 is essential for the
accumulation of eosinophils in the lung [10]. Furthermore,
IL-10 was demonstrated to inhibit IFNg and IL-2 produc-
tion in Th1 cells, and therefore facilitate Th2-like cytokine
production (11). Thus, locally produced IL-5 and IL-10 in
the lung may play important roles in the pathophysiology
of AEP by inducing tissue eosinophilia and by inhibiting
the cytokine production in Th1 cells, respectively.
Our case report suggests that soluble ST2 protein and
activation of Th2 cells may play a role in the pathogenesis
of AEP, although further analysis is required to elucidate
the roles and functions of ST2 in eosinophilic lung disease.Identification of the ligand will most likely improve our
understanding of the biological and pathological functions
of ST2, particularly in Th2-mediated eosinophilic inflam-
mation of the lung.
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